Applied UV, Inc. · OTC:AUVI
Applied UV — IPO Roadshow (June 2021)
30 slides from Applied UV's IPO roadshow presentation, Jun 28, 2021
Slide 1: Applied UV, Inc. Innovations for Infection Prevention
Applied UV, Inc. (NASDAQ:AUVI) Innovations for Infection Prevention JUNE 2021 www.applieduvinc.com Free Writing Prospectus filed pursuant to Rule 433 Registration Statement on Form S - 1 (No. 333 - 257197) June 28, 2021
Slide 2: Safe Harbor Statement
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 2 This presentation may contain “forward - looking statements.” Forward - looking statements reflect the current view about future events. When used in this prospectus, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “inten
Slide 3: Offering and presentation disclaimer
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 3 This presentation highlights basic information about us and the offering. Because it is a summary that has been prepared sole ly for informational purposes, it does not contain all of the information that you should consider before investin
Slide 4: Investing in our securities involves a high degree of risk
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 4 Investing in our securities stock involves a high degree of risk . You should carefully consider the risks described below, as well as the additional risk factors and other information included in our S - 1 Registration Statement or incorpo
Slide 5: Transaction Overview
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 5 Transaction Overview Issuer: Applied UV, Inc. Security: 10.5% Series A Cumulative Perpetual Preferred Stock Ticker / Exchange: AUVIP / NASDAQCM Proposed Offering Size: $18.0 million Over - Allotment Option: 15.0% Price per Share: $25.00 Div
Slide 6: Corporate Overview
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 6 Applied UV offers lab validated, data driven disinfection solutions for air and surface applications. Corporate Overview Air Purification Eliminates: FDA Cleared Medical Device (Class II) Suitable for providing medical grade air purificatio
Slide 7: Recent Airocide Agreements & Purchase Orders
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 7 Installed Airocide at Fenway Park and Jet Blue Park Recent Airocide Agreements & Purchase Orders Exclusive Distribution Agreement for African continent ~$700k $3.5M minimum Over 1 Year 60 Units installed in a school in Uruguay Miscellaneous
Slide 8: Milestones
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 8 Acquire Airocide Technology Platform Partner with Boston Red Sox to install Airocide at Fenway Park and Jet Blue Park Q1 - 2021 Q2 - 2021 Q3 - 2021 Q4 - 2021 Mt. Sinai publishes results of clinical evaluation of our UVC disinfecting system
Slide 9: Corporate Overview (cont'd): Surface Disinfection
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 9 Corporate Overview (cont’d..) Surface Disinfection UVC LED Disinfection Solutions Lumi cide ▪ Joint Development Agreement with Axis Lighting ▪ Patented UVC solution scientifically proven lab to kill 99.99% of surface pathogens, including hu
Slide 10: Markets in Need of Scientifically Proven Disinfection Solutions
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 10 Markets in Need of Scientifically Proven and Effective Disinfection Solutions Commercial Government Sports & Entertainment Venues Retail Tourism / Transportation Healthcare Hospitality • Cruise ships • Airlines • Airports • Car rental • Tr
Slide 11: Our Disinfection Technology and Solutions
Our Disinfection Technology and Solutions Simple, Safe, & Effective: Our Solution for Addressing Coronavirus & Other Pathogens
Slide 12: Slide 12
Slide 13: Proven NASA-based technology for air disinfection
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 13 o Developed with NASA to provide safe, clean air for the International Space Station o FDA Cleared Medical Device (Class II) o Advanced bioconversion technology uses photocatalytic oxidation to fully destroy airborne bacteria, mold, fungi,
Slide 14: Airocide deployed across industry leaders in healthcare, food and wine
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 14 Airocide deployed across industry leaders in healthcare, food and wine - Waiting Areas - Examination Rooms - Clinics - Neonatal - Operating Rooms - Outpatient Surgery - Deployed in over 70 wineries
Slide 15: Tested by Academics, Governmental Organizations and Private Industries
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 15 Tested by Academics, Governmental Organizations and Private Industries Organic Produce wholesaler - Holland ▪ Reduced airborne fungi inside refrigerator cooler by an average of 96.8% in 72 hours Anthrax Study – NASA (USA) ▪ Tests showed as
Slide 16: Official Air Purification Provider of the Boston Red Sox
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 16 ▪ In March 2021, the Boston Red Sox partnered with Applied UV to install the Airocide System at Fenway Park and JetBlue Park (spring training facility) ▪ Project is valued at over $700k in Airocide products 2 million Red Sox fans attend an
Slide 17: Global Distribution
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 17 ▪ Applied UV’s access to capital, scalability and sales and marketing channels allows us to accelerate manufacturing and access new domestic and international markets. © Copyright 2021 Applied UV, Inc. | All Rights Reserved | 17 Global Dis
Slide 18: Airocide capabilities vs. other solutions
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 18 Airocide capabilities vs. the other solutions available in market today Tech/Results (comparison Matrix) • Unwanted irritant by - products such as ozone Exposure to ground - level ozone may result in coughing, throat irritation, inflammati
Slide 19: Lumicide Surface Solutions
Lumi cide Surface Solutions
Slide 20: Joint Development Agreement with Axis Lighting
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 20 Co - Develop and commercialize new LED - based technologies for use in the hospital sector One of the largest independent architectural lighting companies in North America Applied UV, Inc. (NASDAQ:AUVI) Royalty payments to AUVI Joint Devel
Slide 21: Hospitality Segment
Hospitality Segment A global company that manufactures fine mirrors specifically for the hospitality industry © Copyright 2021 Applied UV, Inc. | All Rights Reserved | 21
Slide 22: Financials
Financials
Slide 23: Financials: Un-Audited Pro-Forma for Year Ending December 31
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 23 Financials: Un - Audited Pro - Forma for Year Ending December 31 $9.10 $5.73 $4.53 $4.40 $- $2.00 $4.00 $6.00 $8.00 $10.00 $12.00 $14.00 $16.00 2019 2020 $1.26 $(2.56) $(0.14) $0.64 $(3.00) $(2.50) $(2.00) $(1.50) $(1.00) $(0.50) $- $0.50
Slide 24: Financials: Quarterly Revenue and Adjusted EBITDA
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 24 Financials: (NASDAQ:AUVI) Quarterly Revenue In $ millions $2.1 $1.7 $2.8 $1.6 $2.7 $1.0 $1.5 $2.3 $0.0 $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 Q2 2020 Q3 2019 Q3 2020 Q4 2019 Q4 2020 Q1 2020 Q1 2021 Q2 Q3 Q4 Q1 ‘19 ‘20 ‘19 ‘20 ‘19 ‘20 ‘20 ‘21 $0.3 $
Slide 25: Capitalization / Ownership
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 25 Capitalization / Ownership Common Stock Equivalents as of March 31, 2021 1 # Common Stock 9,402,669 Options (weighted average price of $6.93) 446,314 Warrants (weighted average price of $5.80) 193,169 1. Excludes 2,000 shares of Non - Conv
Slide 26: Leadership
Leadership
Slide 27: Experienced Leadership Team
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 27 Q Saeed CEO and Director Applied UV, Inc. SteriLumen , Inc. Max Munn President, Founder & Director Applied UV, Inc. CEO Munn Works Jim Doyle Chief Operating Officer Applied UV, Inc. SteriLumen , Inc Michael Riccio Chief Financial Officer A
Slide 28: Board of Directors
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 28 • President, Windy City Inc. • CEO Walnut Financial: Sold to Tower Hill Capital Group in 1999 in transaction valued at $400 million • Early - stage investor at BioHorizons, Clarisonic, Encore Medical, GranCare, HealthCare COMPARE, I - Flow
Slide 29: Thank You!
www.applieduvinc.com Thank You! Applied UV, Inc.
Slide 30: APPENDIX: EBITDA Reconciliation
© Copyright 2021 Applied UV, Inc. | All Rights Reserved | 30 APPENDIX: EBITDA Reconciliation - Unaudited Unaudited Pro - Forma – AUVI [year ended 12/31] 2019 2020 Operating Income/(Loss) 1,169,034 ($3,312,892) Stock Based comp 85,000 687,505 Bad debt expense - 50,000 D&A 8,121 17,638 Total $1,262,15